Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1 Apr 2001

Ramus S J, Fishman A, Pharoah P D, Yarkoni S, Altaras M, Ponder B A

Abstract excerpt

PURPOSE: To compare the clinical characteristics and survival of Ashkenazi Jewish ovarian cancer patients with and without BRCA1 and BRCA2 mutations. METHODS: An unselected series of 118 Ashkenazi Jewish ovarian cancer patients were screened for the three common founder mutations in BRCA1 and BRCA2. Patient survival and other clinical characteristics of the tumours were compared in patients with BRCA1 or BRCA2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Israel

Share to Multivariate Analysis

Share to Proportional Hazards Models

Share to Survival Analysis

Source

Identifiers

PMID: 11373105
DOI: 10.1053/ejso.2000.1097

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.PMID 11373105Read ↗

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.Semantic proximity Read ↗

Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.Semantic proximity Read ↗

Hereditary ovarian cancer in Ashkenazi Jews.Semantic proximity Read ↗

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatmentSemantic proximity Read ↗

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.Semantic proximity Read ↗

Improved survival in BRCA2 carriers with ovarian cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.Semantic proximity Read ↗

Breast Conservation Therapy for Invasive Breast Cancer in Ashkenazi Women With BRCA Gene Founder MutationsSemantic proximity Read ↗

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.Semantic proximity Read ↗

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.